Both nonstructural proteins NS1 and NS2 of pneumonia virus of mice are inhibitors of the interferon type I and type III responses in vivo

Journal of Virology

Volumn 85, Issue 9, 2011, Pages 4071-4084

  Heinze, Britta ^a   Frey, Stefanie ^b,c   Mordstein, Markus ^c   Schmitt Gräff, Anette ^c   Ehl, Stephan ^b   Buchholz, Ursula J ^d   Collins, Peter L ^d   Staeheli, Peter ^c   Krempl, Christine D ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; BETA INTERFERON; GAMMA INTERFERON; INTERFERON; INTERFERON LAMBDA 2; INTERFERON RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 28; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GENE DELETION; HISTOPATHOLOGY; HYPEREMIA; IN VIVO STUDY; INTERSTITIAL PNEUMONIA; LUNG LAVAGE; MORTALITY; MOUSE; MURINE PNEUMONIA VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PERITONEUM MACROPHAGE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; CYTOKINES; GENE DELETION; HISTOCYTOCHEMISTRY; INTERFERON TYPE I; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY; MURINE PNEUMONIA VIRUS; PNEUMOVIRUS INFECTIONS; RODENT DISEASES; VIRAL NONSTRUCTURAL PROTEINS; VIRULENCE; VIRULENCE FACTORS; VIRUS REPLICATION;

HUMAN RESPIRATORY SYNCYTIAL VIRUS; MURINE PNEUMONIA VIRUS; MUS; POTATO VIRUS M;

EID: 79955461202     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01365-10     Document Type: Article

References (39)

1. Ank, N., et al. 2008. An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. J. Immunol. 180:2474-2485.
2. Ank, N., et al. 2006. Lambda interferon (IFN-X), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J. Virol. 80:4501-4509.
3. Bitko, V., et al. 2007. Nonstructural proteins of respiratory syncytial virus suppress premature apoptosis by an NF-κB-dependent, interferon-independent mechanism and facilitate virus growth. J. Virol. 81:1786-1795.
4. Bossert, B., S. Marozin, and K.-K. Conzelmann. 2003. Nonstructural proteins NS1 and NS2 of bovine respiratory syncytial virus block activation of interferon regulatory factor 3. J. Virol. 77:8661-8668.
5. Buchholz, U. J., et al. 2009. Deletion of nonstructural proteins NS1 and NS2 from pneumonia virus of mice attenuates viral replication and reduces pulmonary cytokine expression and disease. J. Virol. 83:1969-1980.
6. Byrappa, S., D. K. Gavin, and K. C. Gupta. 1995. A highly efficient procedure for site-specific mutagenesis of full-length plasmids using Vent DNA polymerase. Genome Res. 5:404-407.
7. Contoli, M., et al. 2006. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat. Med. 12:1023-1026.
8. Doyle, S. E., et al. 2006. Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes. Hepatology 44:896-906.
9. Elliott, J., et al. 2007. Respiratory syncytial virus NS1 protein degrades STAT2 by using the elongin-cullin E3 ligase. J. Virol. 81:3428-3436.
10. Frey, S., C. D. Krempl, A. Schmitt-Graff, and S. Ehl. 2008. Role of T cells in virus control and disease after infection with pneumonia virus of mice. J. Virol. 82:11619-11627.
11. Hokeness, K. L., W. A. Kuziel, C. A. Biron, and T. P. Salazar-Mather. 2005. Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-alpha/beta-induced inflammatory responses and antiviral defense in liver. J. Immunol. 174:1549-1556.
12. Johnson, J. E., R. A. Gonzales, S. J. Olson, P. F. Wright, and B. S. Graham. 2007. The histopathology of fatal untreated human respiratory syncytial virus infection. Mod. Pathol. 20:108-119.
13. Kotenko, S. V., et al. 2003. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4:69-77.
14. Krempl, C. D., E. W. Lamirande, and P. L. Collins. 2005. Complete sequence of the RNA genome of pneumonia virus of mice (PVM). Virus Genes 30:237-249.
15. Krempl, C. D., et al. 2007. Identification of a novel virulence factor in recombinant pneumonia virus of mice. J. Virol. 81:9490-9501.
16. Lasfar, A., et al. 2006. Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma. Cancer Res. 66:4468-4477.
17. Ling, Z., K. C. Tran, and M. N. Teng. 2009. Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I. J. Virol. 83:3734-3742.
18. Lo, M. S., R. M. Brazas, and M. J. Holtzman. 2005. Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J. Virol. 79:9315-9319.
19. Marcello, T., et al. 2006. Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology 131:1887-1898.
20. Mifune, K., J. Desmyter, and W. E. Rawls. 1970. Effect of exogenous interferon on rubella virus production in carrier cultures of cells defective in interferon production. Infect. Immun. 2:132-138.
21. Mordstein, M., et al. 2008. Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog. 4:e1000151.
22. Mordstein, M., et al. 2010. Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J. Virol. 84:5670-5677.
23. Muller, U., et al. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918-1921.
24. Pestka, S., C. D. Krause, and M. R. Walter. 2004. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202:8-32.
25. Ramaswamy, M., et al. 2006. Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. Virology 344:328-339.
26. Randall, R. E., and S. Goodbourn. 2008. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89:1-47.
27. Rosenberg, H. F., and J. B. Domachowske. 2008. Pneumonia virus of mice: severe respiratory infection in a natural host. Immunol. Lett. 118:6-12.
28. Schlender, J., B. Bossert, U. Buchholz, and K. K. Conzelmann. 2000. Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response. J. Virol. 74: 8234-8242.
29. Schlender, J., G. Walliser, J. Fricke, and K. K. Conzelmann. 2002. Respiratory syncytial virus fusion protein mediates inhibition of mitogen-induced T-cell proliferation by contact. J. Virol. 76:1163-1170.
30. Sheppard, P., et al. 2003. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 4:63-68.
31. Sommereyns, C, S. Paul, P. Staeheli, and T. Michiels. 2008. IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog. 4:e1000017.
32. Spann, K. M., K.-C. Tran, B. Chi, R. L. Rabin, and P. L. Collins. 2004. Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]. J. Virol. 78:4363-4369. (Erratum, 78:6705.)
33. Spann, K. M., K. C. Tran, and P. L. Collins. 2005. Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-κB, and proinflammatory cytokines. J. Virol. 79: 5353-5362.
34. Teng, M. N., et al. 2000. Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees. J. Virol. 74:9317-9321.
35. Valarcher, J.-F., et al. 2003. Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins. J. Virol. 77:8426-8439.
36. van Pesch, V., H. Lanaya, J. C. Renauld, and T. Michiels. 2004. Characterization of the murine alpha interferon gene family. J. Virol. 78:8219-8228.
37. Welliver, T. P., et al. 2007. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J. Infect. Dis. 195:1126-1136.
38. Wright, P. F., et al. 2006. The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans. J. Infect. Dis. 193:573-581.
39. Zhou, Z., et al. 2007. Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the JAK-STAT pathway and the mitogen-activated protein kinases. J. Virol. 81:7749-7758.